Drug Eye Africa

Tanzania's TMDA joins Medical Device Single Audit Program as affiliate member

The Tanzania Medicines and Medical Devices Authority (TMDA) has officially become an affiliate member of the Medical Device Single Audit Program (MDSAP).

The membership, announced on 24 September 2026, gives TMDA access to official MDSAP audit reports and quality management system (QMS) certification information from participating manufacturers. The authority will also have access to the MDSAP participating facility directory, which contains information on manufacturing sites, audit dates and the responsible MDSAP auditing organisations.

TMDA said this access will strengthen its ability to conduct efficient desk reviews of manufacturers’ QMS compliance. By using existing MDSAP audit outcomes, the authority can reduce unnecessary duplication of regulatory audits, optimise resource use and streamline assessments of medical device manufacturers.

The MDSAP is an international programme that allows a single audit of a medical device manufacturer’s QMS to satisfy the requirements of multiple regulatory jurisdictions. Affiliate membership does not make TMDA a full participating regulatory authority, but provides access to information and closer engagement with the international medical device regulatory community.

TMDA stated the membership will contribute to more efficient regulatory decision-making and timely access to safe, effective and high-quality medical devices for the Tanzanian population.

Source: Tanzania Medicines and Medical Devices Authority (TMDA), “Tanzania Medicines and Medical Devices Authority (TMDA) has officially become an Affiliate Member of the Medical Device Single Audit Program (MDSAP)”, 24 September 2026: https://www.tmda.go.tz/announcements/tanzania-medicines-and-medical-devices-authority-t

About the author

Drug Eye Africa Newsroom

Drug Eye Africa Newsroom

The Drug Eye Africa newsroom reports on medicines regulation, recalls and medicine quality across the African continent. Alerts are matched against the issuing authority's published notice before publication, and corrections are timestamped on the article rather than made silently.

Regulatory alerts and news, direct to your inbox

Independent pharmaceutical news and regulatory intelligence covering Africa.

Scroll to Top